BioNTech-Pfizer vaccine likely to protect against highly infectious UK variant

A new study found that antibodies in patients vaccinated against COVID-19 were able to neutralize a version of the new variant. Researchers tested 10 mutations of the highly contagious UK coronavirus, B117.